New Zealand sticks by pholcodine recommendation

16 December 2020 - Deborah Wilkes

Premium

New Zealand’s Medicines Classification Committee (MCC) is sticking by its recommendation that pholcodine should be reverse-switched from pharmacy-only to pharmacist-only status. The MCC has also made recommendations on fexofenadine, flurbiprofen and ibuprofen.

Click tags below for more information on topics:

Medsafe

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: